Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 4

1(14.3%)

7Total

N/A(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01651624Not ApplicableCompleted

Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District

Role: lead

NCT03683654Completed

Discovery of Novel Biomarkers of Dietary Exposure in the EPIC Calibration Study

Role: collaborator

NCT03612674Not ApplicableUnknown

Adenoma Detection Rate With Endocuff-Assisted Colonoscopy - an Italian Trial

Role: lead

NCT03183700Not ApplicableUnknown

Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women

Role: lead

NCT03587259Not ApplicableUnknown

Innovation in Mammography: Tomosynthesis Pathways

Role: lead

NCT02619123Not ApplicableUnknown

Tailored Screening for Breast Cancer in Premenopausal Women

Role: lead

NCT02777996Not ApplicableCompleted

Italian Lung Cancer Screening Trial (ITALUNG)

Role: lead

NCT02296255Phase 4Completed

Effect of HPV Vaccination on Women Aged 25 Years

Role: lead

All 8 trials loaded